Aga Khan University Clinical Trials Unit (CTU)
- Pakistan
Phase 3 Coronavirus Vaccine in 2900 subjects. Site previously performed Phase 2a trial for NVGH Glycoconjugate Vaccine in 160 participants, Phase 4 for mOPV1 and bOPV1&3 oral polio vaccines in ...
- Size Other
- Previous clinical trials More than 10
- Staff None